tiprankstipranks
Chugai Pharmaceutical Co Ltd (CHGCF)
OTHER OTC:CHGCF
US Market
CHGCF
Chugai Pharmaceutical Co
RESEARCH TOOLSreports
Want to see CHGCF full AI Analyst Report?

Chugai Pharmaceutical Co (CHGCF) Financial Statements

22 Followers

Chugai Pharmaceutical Co Financial Overview

Chugai Pharmaceutical Co's market cap is currently $76.71B. The company's EPS TTM is $0.43943457999999996; its P/E ratio is 30.70; and it has a dividend yield of 2.38%. Chugai Pharmaceutical Co is scheduled to report earnings on April 24, 2026, and the estimated EPS forecast is $0.47. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 1.26T¥ 1.17T¥ 1.11T¥ 1.26T¥ 999.76B
Gross Profit¥ 894.25B¥ 830.75B¥ 693.01B¥ 783.06B¥ 660.27B
Operating Income¥ 590.19B¥ 543.91B¥ 415.67B¥ 533.94B¥ 433.74B
EBITDA¥ 631.37B¥ 574.80B¥ 475.64B¥ 562.66B¥ 450.30B
Net Income¥ 434.01B¥ 387.32B¥ 325.47B¥ 374.43B¥ 303.00B
Balance Sheet
Cash & Short-Term Investments¥ 979.70B¥ 996.35B¥ 738.98B¥ 503.11B¥ 471.97B
Total Assets¥ 2.47T¥ 2.21T¥ 1.93T¥ 1.87T¥ 1.54T
Total Debt¥ 0.00¥ 10.90B¥ 13.46B¥ 14.11B¥ 16.04B
Net Debt¥ -426.60B¥ -529.30B¥ -445.22B¥ -208.06B¥ -251.71B
Total Liabilities¥ 442.86B¥ 306.87B¥ 306.97B¥ 445.37B¥ 350.68B
Stockholders' Equity¥ 2.03T¥ 1.90T¥ 1.63T¥ 1.42T¥ 1.19T
Cash Flow
Free Cash Flow¥ 313.18B¥ 396.68B¥ 335.67B¥ 172.87B¥ 206.76B
Operating Cash Flow¥ 389.45B¥ 447.60B¥ 409.93B¥ 244.11B¥ 279.63B
Investing Cash Flow¥ -204.87B¥ -227.37B¥ -37.29B¥ -145.99B¥ -118.93B
Financing Cash Flow¥ -307.46B¥ -141.01B¥ -139.33B¥ -145.64B¥ -107.41B
Currency in JPY

Chugai Pharmaceutical Co Earnings and Revenue History

Income Statement >

Chugai Pharmaceutical Co Debt to Assets

Balance Sheet >

Chugai Pharmaceutical Co Cash Flow

Cash Flow >

Chugai Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >